Medpace Insider Buying: General Counsel Buys 3,500 Shares, Signals Confidence for 2026 GrowthMedpace insider buys 3,500 shares at $138.87, signaling confidence amid bullish trends, low valuation, and potential future catalysts.Medpace Holdings Inc Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 18/02/2026, 23:33 3 minutes to read